The activity of GCase is decreased in PD brains with heterozygous GBA1 mutations (PD+GBA), with the greatest decrease (58%) in the substantia nigra,4 the area of the brain with the greatest PD pathology. This evidence concerns the gene GBA1 and Parkinson disease.